Body fluid management as a treatment for obstructive sleep apnea: a new possibility for sodium-glucose cotransporter 2 inhibitors
Hypertens Res
.
2024 Dec 20.
doi: 10.1038/s41440-024-02063-1.
Online ahead of print.
Author
Hiromitsu Sekizuka
1
Affiliation
1
Department of Internal Medicine, FUJITSU Clinic, Kawasaki, Japan.
[email protected]
.
PMID:
39706888
DOI:
10.1038/s41440-024-02063-1
No abstract available
Keywords:
Fluid shift; Heart failure; Novel therapy; Sleep-disordered breathing; Tofogliflozin.
Publication types
Editorial
Comment